<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-24161" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Left Ventricular Failure</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Chahine</surname>
            <given-names>Johnny</given-names>
          </name>
          <aff>University of Minnesota</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Alvey</surname>
            <given-names>Heidi</given-names>
          </name>
          <aff>Baylor Scott &#x00026; White/Texas A&#x00026;M SOM</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Johnny Chahine declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Heidi Alvey declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>26</day>
          <month>6</month>
          <year>2023</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-24161.s1" sec-type="Continuing Education Activity">
        <title>Continuing Education Activity</title>
        <p>Left heart failure occurs when there is dysfunction of the left ventricle, resulting insufficient delivery of blood to vital organs. Left ventricular failure can be further subdivided into heart failure with preserved ejection fraction (HFpEF) with ejection fraction over 50 percent, heart failure with reduced ejection fraction (HFrEF) with ejection fraction less than 40 percent, or heart failure with mid-range ejection fraction, with ejection fraction between 41 and 49 percent. This activity describes the evaluation and management of left heart failure and highlights the role of the interprofessional team in improving care for affected patients.</p>
        <p>
<bold>Objectives:</bold>
<list list-type="bullet"><list-item><p>Describe the risk factors for developing left heart failure.</p></list-item><list-item><p>Review the clinical manifestations of left heart failure.</p></list-item><list-item><p>Identify the latest treatment options for left heart failure.</p></list-item><list-item><p>Explain the importance of improving care coordination amongst interprofessional team members to decrease mortality of patients with left heart failure.</p></list-item></list>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=24161&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=24161">Access free multiple choice questions on this topic.</ext-link>
</p>
      </sec>
      <sec id="article-24161.s2" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p>The heart is comprised of the pericardium, myocardium, and endocardium. Pathology in any of those structures can lead to heart failure.&#x000a0;Left ventricular failure occurs when there is dysfunction of the left ventricle&#x000a0;causing insufficient delivery of blood to vital body organs.&#x000a0;Left ventricular failure can further subdivide into heart failure with preserved ejection fraction (HFpEF with EF over 50%), heart failure with reduced ejection fraction (HFrEF with EF less than 40%), or heart failure with mid-range ejection fraction (EF between 41 and 49 percent).</p>
      </sec>
      <sec id="article-24161.s3" sec-type="Etiology">
        <title>Etiology</title>
        <p>The most common etiologies of left heart failure are coronary artery disease and hypertension. The latter can cause left heart failure through left ventricular hypertrophy (leading to HFpEF), and also serves as a risk factor for coronary artery disease (which can lead&#x000a0;to HFrEF). Diabetes, smoking, obesity, male gender,&#x000a0;and&#x000a0;a sedentary lifestyle&#x000a0;are also considered risk factors.<xref ref-type="bibr" rid="article-24161.r1">[1]</xref><xref ref-type="bibr" rid="article-24161.r2">[2]</xref><xref ref-type="bibr" rid="article-24161.r3">[3]</xref> Many of these causes are preventable, and as such&#x000a0;risk factor control remains of extreme importance in preventing heart failure.<xref ref-type="bibr" rid="article-24161.r4">[4]</xref></p>
      </sec>
      <sec id="article-24161.s4" sec-type="Epidemiology">
        <title>Epidemiology</title>
        <p>Heart failure is more prevalent and has a higher incidence in the elderly population. Approximately 5.7 million people in the United States have diagnosed heart failure. The incidence&#x000a0;is around 10 per 1000 in people over 65.<xref ref-type="bibr" rid="article-24161.r5">[5]</xref><xref ref-type="bibr" rid="article-24161.r6">[6]</xref>Approximately 50% of all patients with heart failure are considered to have HFrEF; this diagnosis is becoming more prevalent with time.<xref ref-type="bibr" rid="article-24161.r7">[7]</xref><xref ref-type="bibr" rid="article-24161.r8">[8]</xref> HFpEF, as opposed to&#x000a0;HFrEF, is more common in women (79% versus 49%) and also tends to affect&#x000a0;an older population.<xref ref-type="bibr" rid="article-24161.r9">[9]</xref></p>
      </sec>
      <sec id="article-24161.s5" sec-type="Pathophysiology">
        <title>Pathophysiology</title>
        <p>Multiple mechanisms can lead to left heart failure. Chronic or poorly controlled hypertension causes increased afterload and therefore&#x000a0;increased cardiac&#x000a0;workload, which can lead to hypertrophy of the left ventricle. Initially, this hypertrophy serves as a compensatory mechanism and can help maintain cardiac output, but long-term can&#x000a0;inhibit relaxation of the myocardium leading to impaired cardiac filling and decrease left ventricular output. Coronary arterial disease causes direct ischemic damage to the myocardium, leading to remodeling and scar formation, which decreases contractility and&#x000a0;cardiac output. Arrhythmias can cause remodeling, but in general,&#x000a0;decrease cardiac output by impaired ventricular filling and decreased ventricular relaxation.&#x000a0;Cardiomyopathies encompass a diverse pathologic spectrum and have variable mechanisms causing cardiac dysfunction.<xref ref-type="bibr" rid="article-24161.r10">[10]</xref></p>
      </sec>
      <sec id="article-24161.s6" sec-type="History and Physical">
        <title>History and Physical</title>
        <p>Patients with left heart failure may present with complaints of shortness of breath (often on exertion, a sensitivity of 89%), orthopnea (a specificity of 89%), paroxysmal nocturnal dyspnea and/or symptoms of volume overload (e.g., leg swelling, weight gain, increased abdominal girth, or right upper quadrant pain due to liver congestion).<xref ref-type="bibr" rid="article-24161.r11">[11]</xref> Interestingly, some patients with advanced disease might experience weight loss, referred to as "cardiac cachexia."<xref ref-type="bibr" rid="article-24161.r12">[12]</xref></p>
        <p>On physical exam, the most common signs encountered are:</p>
        <list list-type="bullet">
          <list-item>
            <p>Rales on lung auscultation indicative of pulmonary edema</p>
          </list-item>
          <list-item>
            <p>Decreased breath sounds on lung auscultation suggestive of pleural effusion</p>
          </list-item>
          <list-item>
            <p>S3 gallop&#x000a0;on heart auscultation indicative of elevated left ventricular end-diastolic pressure</p>
          </list-item>
          <list-item>
            <p>Point of maximal impulse displaced laterally on palpation characteristic of increased heart size</p>
          </list-item>
          <list-item>
            <p>Jugular venous distention (jugular venous pressure over 8 cm of water) indicative of elevated right atrial pressure</p>
          </list-item>
          <list-item>
            <p>Positive hepatojugular reflux (exerting manual pressure on the congested liver causing increased jugular venous pressures)</p>
          </list-item>
          <list-item>
            <p>Increased abdominal girth due to ascites</p>
          </list-item>
          <list-item>
            <p>Swelling of the scrotum</p>
          </list-item>
          <list-item>
            <p>Low blood pressure and rapid heart rate can occur in severely decompensated failure&#x000a0;due to decreased cardiac output</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-24161.s7" sec-type="Evaluation">
        <title>Evaluation</title>
        <p>The diagnosis of heart failure is clinical. However, several tests are available for further evaluation:</p>
        <list list-type="bullet">
          <list-item>
            <p>Laboratory tests:&#x000a0;brain natriuretic peptide (BNP) or NT-proBNP&#x000a0;may be the most helpful&#x000a0;as it can differentiate&#x000a0;acute&#x000a0;heart failure from other causes of shortness of breath.&#x000a0;However, this test lacks specificity, and a high level of this hormone is not diagnostic of acute heart failure.<xref ref-type="bibr" rid="article-24161.r11">[11]</xref><xref ref-type="bibr" rid="article-24161.r13">[13]</xref> Other laboratory tests include troponin T (to detect myocardial infarction, although the levels may be high due to heart failure itself), complete blood count, basic metabolic panel (low&#x000a0;sodium, in particular,&#x000a0;indicates advanced disease)&#x000a0;and liver function tests (to detect liver&#x000a0;injury due to volume overload).</p>
          </list-item>
          <list-item>
            <p>Electrocardiography can show nonspecific findings, like ischemic changes, left ventricular hypertrophy, or arrhythmias.</p>
          </list-item>
          <list-item>
            <p>Echocardiography can help distinguish HFrEF from HFpEF&#x000a0;by determining the&#x000a0;ejection fraction, and&#x000a0;diastolic left ventricular function can evaluate associated regional wall motion abnormalities that may&#x000a0;be suggestive of an&#x000a0;ischemic component,&#x000a0;as well as&#x000a0;valvular and pericardial pathologies.</p>
          </list-item>
          <list-item>
            <p>Coronary angiography is indicated in patients with anginal symptoms and may also be indicated in patients with worsening heart failure symptoms.<xref ref-type="bibr" rid="article-24161.r14">[14]</xref></p>
          </list-item>
        </list>
      </sec>
      <sec id="article-24161.s8" sec-type="Treatment / Management">
        <title>Treatment / Management</title>
        <p>Patients should receive education on the importance of lifestyle modification for&#x000a0;improving the outcome of their disease. This includes reasonable salt consumption and avoidance of alcohol, nicotine, and recreational drugs.</p>
        <p>Treating the underlying cause is of extreme importance as some heart failure conditions may be reversible when the precipitating factors&#x000a0;are&#x000a0;addressed, like&#x000a0;cardiomyopathies induced by alcohol, tachycardia or ischemia. Tight control of blood pressure will also help prevent further deterioration.<xref ref-type="bibr" rid="article-24161.r15">[15]</xref>Besides loop diuretics for volume overload, the pharmacologic treatment differs between HFrEF and HFpEF <xref ref-type="bibr" rid="article-24161.r16">[16]</xref><xref ref-type="bibr" rid="article-24161.r17">[17]</xref><xref ref-type="bibr" rid="article-24161.r18">[18]</xref>: -For HFrEF, the mainstay of treatment is the combination of an angiotensin-converting enzyme (ACE) inhibitors or angiotensin II receptor blockers (ARBs) with a beta blocker (carvedilol, metoprolol or bisoprolol). If the patient remains symptomatic on a maximal dose of ACE inhibitor or ARB,&#x000a0;an angiotensin receptor-neprilysin inhibitor may be substituted. Other&#x000a0;medications include hydralazine, nitrates, mineralocorticoid receptor antagonists such as spironolactone, ivabradine, and digoxin (as a last resort). Nitrates in combination with hydralazine may be especially efficacious in African American patients. Digoxin, ivabradine and the diuretics have not been shown to offer any mortality benefit.</p>
        <p>- For HFpEF, the treatment focuses on the underlying cause or contributing factors: control of blood pressure, revascularization if ischemic cardiomyopathy, and management of arrhythmias. A mineralocorticoid receptor antagonist may be beneficial in these patients.</p>
        <p>Severely symptomatic patients with an ejection fraction less than 35%&#x000a0;should obtain a referral for implantable cardioverter-defibrillator (ICD) or cardiac resynchronization therapy (CRT) (depending on QRS width and the type of&#x000a0;intraventricular conduction delay) after medical optimization. In advanced cases,&#x000a0;mechanical circulatory assist devices such as an LVAD, continuous infusion of inotropic medications such as dobutamine or milrinone (which is still possible in the ambulatory setting), and cardiac transplantation are options.</p>
      </sec>
      <sec id="article-24161.s9" sec-type="Differential Diagnosis">
        <title>Differential Diagnosis</title>
        <list list-type="bullet">
          <list-item>
            <p>When approaching a patient with shortness of breath on exertion, a broad differential diagnosis exists. A patient with established left heart failure might have a concomitant disease that might contribute to the patient's presentation, and additional workup for other conditions is warranted in case of atypical presentations. Those conditions include other cardiovascular causes (like primary pulmonary hypertension), pulmonary causes (like chronic obstructive pulmonary disease and interstitial lung disease) and extra-cardiopulmonary causes (like anemia).</p>
          </list-item>
          <list-item>
            <p>Isolated lower limb edema is less likely heart failure, and other causes must be ruled out first, like venous insufficiency, cirrhosis, nephrotic syndrome, lymphedema and&#x000a0;thrombosis of the veins.</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-24161.s10" sec-type="Staging">
        <title>Staging</title>
        <p>The "2009 focused update incorporated into the ACC/AHA 2005 guidelines for the diagnosis and management of heart&#x000a0;failure in adults" recommends a staging for heart failure.[<xref ref-type="bibr" rid="article-24161.r19">[19]</xref> Patients with stages A and B are those who are asymptomatic but are prone to develop heart failure&#x000a0;in the future, for example, diabetic&#x000a0;and hypertensive patients. Stage B differs from stage A by the presence of&#x000a0;a structural cardiac abnormality, like ventricular hypertrophy or systolic dysfunction, but again with no symptoms. Stage C and D patients include those who have ever experienced symptoms of heart failure. Stage D patients are those with severe heart failure&#x000a0;who require advanced treatment like mechanical support, around-the-clock inotropic agents and heart transplantation.Stage C and D patients can be further classified&#x000a0;based on the New York Heart Association (NYHA) Functional Classification:&#x000a0;</p>
        <list list-type="bullet">
          <list-item>
            <p>Class I: symptoms not restricting daily activities.</p>
          </list-item>
          <list-item>
            <p>Class II:&#x000a0;symptoms occurring at moderate effort slightly restricting daily activities.</p>
          </list-item>
          <list-item>
            <p>Class III: symptoms occurring at minimal effort with significant restriction of daily activities.</p>
          </list-item>
          <list-item>
            <p>Class IV: debilitating symptoms are occurring at rest.</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-24161.s11" sec-type="Prognosis">
        <title>Prognosis</title>
        <p>The mortality rate in heart failure in 2008 was&#x000a0;18.2 per 100,000 for males and 15.8 per&#x000a0;100,000 for females based on the "Morbidity and Mortality: 2012&#x000a0;Chart Book on Cardiovascular, Lung and Blood Diseases". Patients&#x000a0;with HFpEF have&#x000a0;been known to have a lower mortality rate than those with HFrEF.<xref ref-type="bibr" rid="article-24161.r20">[20]</xref></p>
        <p>Multiple variables have associations with worse outcome in heart failure: male gender, advancing age, low ejection fraction, high&#x000a0;NYHA functional class, low hematocrit, and sodium levels, high brain natriuretic peptide,&#x000a0;low peak exercise oxygen uptake, wide QRS, renal failure, low blood pressure, elevated heart rate, and volume overload refractory to medical treatment.<xref ref-type="bibr" rid="article-24161.r19">[19]</xref><xref ref-type="bibr" rid="article-24161.r21">[21]</xref></p>
      </sec>
      <sec id="article-24161.s12" sec-type="Complications">
        <title>Complications</title>
        <p>Left heart failure can be complicated with severe volume overload leading to respiratory distress and anasarca as well as arrhythmias (tachyarrhythmias or bradyarrhythmias),&#x000a0;cardiogenic shock due to pump failure and death.&#x000a0;It was also reported that pulmonary embolism, acute coronary syndrome, cerebrovascular accidents and rupture of the myocardium are common causes of sudden death in patients with heart failure.<xref ref-type="bibr" rid="article-24161.r22">[22]</xref> In addition to implantable cardioverter-defibrillators, several medications (stated above) reduce mortality in left heart failure and initiation of therapy should be as soon as indicated.</p>
      </sec>
      <sec id="article-24161.s13" sec-type="Deterrence and Patient Education">
        <title>Deterrence and Patient Education</title>
        <p>Compliance with lifestyle modification and pharmacologic treatment and control of precipitating factors (like hypertension and arrhythmias)&#x000a0;are crucial to prevent hospitalizations for heart failure exacerbation and improve the quality of life. Many of those precipitating factors are potentially under patient control. That is why patient education is an integral part of a multidisciplinary approach to decrease mortality and morbidity due to heart failure.</p>
      </sec>
      <sec id="article-24161.s14" sec-type="Enhancing Healthcare Team Outcomes ">
        <title>Enhancing Healthcare Team Outcomes </title>
        <p>an interprofessional approach is crucial in patients with advanced heart failure with an increased risk of readmissions.<xref ref-type="bibr" rid="article-24161.r16">[16]</xref><xref ref-type="bibr" rid="article-24161.r23">[23]</xref> In a systematic review of 29 randomized controlled trials, an interprofessional approach decreased heart-failure related hospital admissions by 27%&#x000a0;and all-cause mortality by around 25%. This approach was also cost-effective. Well-trained nurses are an integral part of this approach since heart failure clinics led by nurses and&#x000a0;in coordination with the patients' providers were very successful in enhancing patient outcome. In&#x000a0;addition&#x000a0;to the availability of heart failure clinics, training personnel in heart failure management and patient education are cornerstones to a successful an interprofessional approach. Telephone follow up reduced hospital readmissions due to heart failure but not mortality. [level II]</p>
      </sec>
      <sec id="article-24161.s15">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=24161&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=24161">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://mdsearchlight.com/heart-health/left-ventricular-failure/?utm_source=pubmedlink&#x00026;utm_campaign=MDS&#x00026;utm_content=24161">Click here for a simplified version.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/24161/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=24161">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <ref-list id="article-24161.s16">
        <title>References</title>
        <ref id="article-24161.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>He</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Ogden</surname>
                <given-names>LG</given-names>
              </name>
              <name>
                <surname>Bazzano</surname>
                <given-names>LA</given-names>
              </name>
              <name>
                <surname>Vupputuri</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Loria</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Whelton</surname>
                <given-names>PK</given-names>
              </name>
            </person-group>
            <article-title>Risk factors for congestive heart failure in US men and women: NHANES I epidemiologic follow-up study.</article-title>
            <source>Arch Intern Med</source>
            <year>2001</year>
            <month>Apr</month>
            <day>09</day>
            <volume>161</volume>
            <issue>7</issue>
            <fpage>996</fpage>
            <page-range>996-1002</page-range>
            <pub-id pub-id-type="pmid">11295963</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24161.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ho</surname>
                <given-names>KK</given-names>
              </name>
              <name>
                <surname>Pinsky</surname>
                <given-names>JL</given-names>
              </name>
              <name>
                <surname>Kannel</surname>
                <given-names>WB</given-names>
              </name>
              <name>
                <surname>Levy</surname>
                <given-names>D</given-names>
              </name>
            </person-group>
            <article-title>The epidemiology of heart failure: the Framingham Study.</article-title>
            <source>J Am Coll Cardiol</source>
            <year>1993</year>
            <month>Oct</month>
            <volume>22</volume>
            <issue>4 Suppl A</issue>
            <fpage>6A</fpage>
            <page-range>6A-13A</page-range>
            <pub-id pub-id-type="pmid">8376698</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24161.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Dunlay</surname>
                <given-names>SM</given-names>
              </name>
              <name>
                <surname>Weston</surname>
                <given-names>SA</given-names>
              </name>
              <name>
                <surname>Jacobsen</surname>
                <given-names>SJ</given-names>
              </name>
              <name>
                <surname>Roger</surname>
                <given-names>VL</given-names>
              </name>
            </person-group>
            <article-title>Risk factors for heart failure: a population-based case-control study.</article-title>
            <source>Am J Med</source>
            <year>2009</year>
            <month>Nov</month>
            <volume>122</volume>
            <issue>11</issue>
            <fpage>1023</fpage>
            <page-range>1023-8</page-range>
            <pub-id pub-id-type="pmid">19854330</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24161.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Vasan</surname>
                <given-names>RS</given-names>
              </name>
              <name>
                <surname>Levy</surname>
                <given-names>D</given-names>
              </name>
            </person-group>
            <article-title>The role of hypertension in the pathogenesis of heart failure. A clinical mechanistic overview.</article-title>
            <source>Arch Intern Med</source>
            <year>1996</year>
            <month>Sep</month>
            <day>09</day>
            <volume>156</volume>
            <issue>16</issue>
            <fpage>1789</fpage>
            <page-range>1789-96</page-range>
            <pub-id pub-id-type="pmid">8790072</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24161.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <collab>Writing Group Members</collab>
              <name>
                <surname>Mozaffarian</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Benjamin</surname>
                <given-names>EJ</given-names>
              </name>
              <name>
                <surname>Go</surname>
                <given-names>AS</given-names>
              </name>
              <name>
                <surname>Arnett</surname>
                <given-names>DK</given-names>
              </name>
              <name>
                <surname>Blaha</surname>
                <given-names>MJ</given-names>
              </name>
              <name>
                <surname>Cushman</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Das</surname>
                <given-names>SR</given-names>
              </name>
              <name>
                <surname>de Ferranti</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Despr&#x000e9;s</surname>
                <given-names>JP</given-names>
              </name>
              <name>
                <surname>Fullerton</surname>
                <given-names>HJ</given-names>
              </name>
              <name>
                <surname>Howard</surname>
                <given-names>VJ</given-names>
              </name>
              <name>
                <surname>Huffman</surname>
                <given-names>MD</given-names>
              </name>
              <name>
                <surname>Isasi</surname>
                <given-names>CR</given-names>
              </name>
              <name>
                <surname>Jim&#x000e9;nez</surname>
                <given-names>MC</given-names>
              </name>
              <name>
                <surname>Judd</surname>
                <given-names>SE</given-names>
              </name>
              <name>
                <surname>Kissela</surname>
                <given-names>BM</given-names>
              </name>
              <name>
                <surname>Lichtman</surname>
                <given-names>JH</given-names>
              </name>
              <name>
                <surname>Lisabeth</surname>
                <given-names>LD</given-names>
              </name>
              <name>
                <surname>Liu</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Mackey</surname>
                <given-names>RH</given-names>
              </name>
              <name>
                <surname>Magid</surname>
                <given-names>DJ</given-names>
              </name>
              <name>
                <surname>McGuire</surname>
                <given-names>DK</given-names>
              </name>
              <name>
                <surname>Mohler</surname>
                <given-names>ER</given-names>
              </name>
              <name>
                <surname>Moy</surname>
                <given-names>CS</given-names>
              </name>
              <name>
                <surname>Muntner</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Mussolino</surname>
                <given-names>ME</given-names>
              </name>
              <name>
                <surname>Nasir</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Neumar</surname>
                <given-names>RW</given-names>
              </name>
              <name>
                <surname>Nichol</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Palaniappan</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Pandey</surname>
                <given-names>DK</given-names>
              </name>
              <name>
                <surname>Reeves</surname>
                <given-names>MJ</given-names>
              </name>
              <name>
                <surname>Rodriguez</surname>
                <given-names>CJ</given-names>
              </name>
              <name>
                <surname>Rosamond</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Sorlie</surname>
                <given-names>PD</given-names>
              </name>
              <name>
                <surname>Stein</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Towfighi</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Turan</surname>
                <given-names>TN</given-names>
              </name>
              <name>
                <surname>Virani</surname>
                <given-names>SS</given-names>
              </name>
              <name>
                <surname>Woo</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Yeh</surname>
                <given-names>RW</given-names>
              </name>
              <name>
                <surname>Turner</surname>
                <given-names>MB</given-names>
              </name>
              <collab>American Heart Association Statistics Committee</collab>
              <collab>Stroke Statistics Subcommittee</collab>
            </person-group>
            <article-title>Heart Disease and Stroke Statistics-2016 Update: A Report From the American Heart Association.</article-title>
            <source>Circulation</source>
            <year>2016</year>
            <month>Jan</month>
            <day>26</day>
            <volume>133</volume>
            <issue>4</issue>
            <fpage>e38</fpage>
            <page-range>e38-360</page-range>
            <pub-id pub-id-type="pmid">26673558</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24161.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lloyd-Jones</surname>
                <given-names>DM</given-names>
              </name>
              <name>
                <surname>Larson</surname>
                <given-names>MG</given-names>
              </name>
              <name>
                <surname>Leip</surname>
                <given-names>EP</given-names>
              </name>
              <name>
                <surname>Beiser</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>D'Agostino</surname>
                <given-names>RB</given-names>
              </name>
              <name>
                <surname>Kannel</surname>
                <given-names>WB</given-names>
              </name>
              <name>
                <surname>Murabito</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Vasan</surname>
                <given-names>RS</given-names>
              </name>
              <name>
                <surname>Benjamin</surname>
                <given-names>EJ</given-names>
              </name>
              <name>
                <surname>Levy</surname>
                <given-names>D</given-names>
              </name>
              <collab>Framingham Heart Study</collab>
            </person-group>
            <article-title>Lifetime risk for developing congestive heart failure: the Framingham Heart Study.</article-title>
            <source>Circulation</source>
            <year>2002</year>
            <month>Dec</month>
            <day>10</day>
            <volume>106</volume>
            <issue>24</issue>
            <fpage>3068</fpage>
            <page-range>3068-72</page-range>
            <pub-id pub-id-type="pmid">12473553</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24161.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Owan</surname>
                <given-names>TE</given-names>
              </name>
              <name>
                <surname>Hodge</surname>
                <given-names>DO</given-names>
              </name>
              <name>
                <surname>Herges</surname>
                <given-names>RM</given-names>
              </name>
              <name>
                <surname>Jacobsen</surname>
                <given-names>SJ</given-names>
              </name>
              <name>
                <surname>Roger</surname>
                <given-names>VL</given-names>
              </name>
              <name>
                <surname>Redfield</surname>
                <given-names>MM</given-names>
              </name>
            </person-group>
            <article-title>Trends in prevalence and outcome of heart failure with preserved ejection fraction.</article-title>
            <source>N Engl J Med</source>
            <year>2006</year>
            <month>Jul</month>
            <day>20</day>
            <volume>355</volume>
            <issue>3</issue>
            <fpage>251</fpage>
            <page-range>251-9</page-range>
            <pub-id pub-id-type="pmid">16855265</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24161.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bursi</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Weston</surname>
                <given-names>SA</given-names>
              </name>
              <name>
                <surname>Redfield</surname>
                <given-names>MM</given-names>
              </name>
              <name>
                <surname>Jacobsen</surname>
                <given-names>SJ</given-names>
              </name>
              <name>
                <surname>Pakhomov</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Nkomo</surname>
                <given-names>VT</given-names>
              </name>
              <name>
                <surname>Meverden</surname>
                <given-names>RA</given-names>
              </name>
              <name>
                <surname>Roger</surname>
                <given-names>VL</given-names>
              </name>
            </person-group>
            <article-title>Systolic and diastolic heart failure in the community.</article-title>
            <source>JAMA</source>
            <year>2006</year>
            <month>Nov</month>
            <day>08</day>
            <volume>296</volume>
            <issue>18</issue>
            <fpage>2209</fpage>
            <page-range>2209-16</page-range>
            <pub-id pub-id-type="pmid">17090767</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24161.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Masoudi</surname>
                <given-names>FA</given-names>
              </name>
              <name>
                <surname>Havranek</surname>
                <given-names>EP</given-names>
              </name>
              <name>
                <surname>Smith</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Fish</surname>
                <given-names>RH</given-names>
              </name>
              <name>
                <surname>Steiner</surname>
                <given-names>JF</given-names>
              </name>
              <name>
                <surname>Ordin</surname>
                <given-names>DL</given-names>
              </name>
              <name>
                <surname>Krumholz</surname>
                <given-names>HM</given-names>
              </name>
            </person-group>
            <article-title>Gender, age, and heart failure with preserved left ventricular systolic function.</article-title>
            <source>J Am Coll Cardiol</source>
            <year>2003</year>
            <month>Jan</month>
            <day>15</day>
            <volume>41</volume>
            <issue>2</issue>
            <fpage>217</fpage>
            <page-range>217-23</page-range>
            <pub-id pub-id-type="pmid">12535812</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24161.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Pazos-L&#x000f3;pez</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Peteiro-V&#x000e1;zquez</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Carc&#x000ed;a-Campos</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Garc&#x000ed;a-Bueno</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>de Torres</surname>
                <given-names>JP</given-names>
              </name>
              <name>
                <surname>Castro-Beiras</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>The causes, consequences, and treatment of left or right heart failure.</article-title>
            <source>Vasc Health Risk Manag</source>
            <year>2011</year>
            <volume>7</volume>
            <fpage>237</fpage>
            <page-range>237-54</page-range>
            <pub-id pub-id-type="pmid">21603593</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24161.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Mant</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Doust</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Roalfe</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Barton</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Cowie</surname>
                <given-names>MR</given-names>
              </name>
              <name>
                <surname>Glasziou</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Mant</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>McManus</surname>
                <given-names>RJ</given-names>
              </name>
              <name>
                <surname>Holder</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Deeks</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Fletcher</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Qume</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Sohanpal</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Sanders</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Hobbs</surname>
                <given-names>FD</given-names>
              </name>
            </person-group>
            <article-title>Systematic review and individual patient data meta-analysis of diagnosis of heart failure, with modelling of implications of different diagnostic strategies in primary care.</article-title>
            <source>Health Technol Assess</source>
            <year>2009</year>
            <month>Jul</month>
            <volume>13</volume>
            <issue>32</issue>
            <fpage>1</fpage>
            <page-range>1-207, iii</page-range>
            <pub-id pub-id-type="pmid">19586584</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24161.r12">
          <label>12</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Anker</surname>
                <given-names>SD</given-names>
              </name>
              <name>
                <surname>Sharma</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>The syndrome of cardiac cachexia.</article-title>
            <source>Int J Cardiol</source>
            <year>2002</year>
            <month>Sep</month>
            <volume>85</volume>
            <issue>1</issue>
            <fpage>51</fpage>
            <page-range>51-66</page-range>
            <pub-id pub-id-type="pmid">12163209</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24161.r13">
          <label>13</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kelder</surname>
                <given-names>JC</given-names>
              </name>
              <name>
                <surname>Cramer</surname>
                <given-names>MJ</given-names>
              </name>
              <name>
                <surname>van Wijngaarden</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>van Tooren</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Mosterd</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Moons</surname>
                <given-names>KG</given-names>
              </name>
              <name>
                <surname>Lammers</surname>
                <given-names>JW</given-names>
              </name>
              <name>
                <surname>Cowie</surname>
                <given-names>MR</given-names>
              </name>
              <name>
                <surname>Grobbee</surname>
                <given-names>DE</given-names>
              </name>
              <name>
                <surname>Hoes</surname>
                <given-names>AW</given-names>
              </name>
            </person-group>
            <article-title>The diagnostic value of physical examination and additional testing in primary care patients with suspected heart failure.</article-title>
            <source>Circulation</source>
            <year>2011</year>
            <month>Dec</month>
            <day>20</day>
            <volume>124</volume>
            <issue>25</issue>
            <fpage>2865</fpage>
            <page-range>2865-73</page-range>
            <pub-id pub-id-type="pmid">22104551</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24161.r14">
          <label>14</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ferreira</surname>
                <given-names>JP</given-names>
              </name>
              <name>
                <surname>Rossignol</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Demissei</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Sharma</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Girerd</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Anker</surname>
                <given-names>SD</given-names>
              </name>
              <name>
                <surname>Cleland</surname>
                <given-names>JG</given-names>
              </name>
              <name>
                <surname>Dickstein</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Filippatos</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Hillege</surname>
                <given-names>HL</given-names>
              </name>
              <name>
                <surname>Lang</surname>
                <given-names>CC</given-names>
              </name>
              <name>
                <surname>Metra</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Ng</surname>
                <given-names>LL</given-names>
              </name>
              <name>
                <surname>Ponikowski</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Samani</surname>
                <given-names>NJ</given-names>
              </name>
              <name>
                <surname>van Veldhuisen</surname>
                <given-names>DJ</given-names>
              </name>
              <name>
                <surname>Zwinderman</surname>
                <given-names>AH</given-names>
              </name>
              <name>
                <surname>Voors</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Zannad</surname>
                <given-names>F</given-names>
              </name>
            </person-group>
            <article-title>Coronary angiography in worsening heart failure: determinants, findings and prognostic implications.</article-title>
            <source>Heart</source>
            <year>2018</year>
            <month>Apr</month>
            <volume>104</volume>
            <issue>7</issue>
            <fpage>606</fpage>
            <page-range>606-613</page-range>
            <pub-id pub-id-type="pmid">28798192</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24161.r15">
          <label>15</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Yancy</surname>
                <given-names>CW</given-names>
              </name>
              <name>
                <surname>Jessup</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Bozkurt</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Butler</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Casey</surname>
                <given-names>DE</given-names>
              </name>
              <name>
                <surname>Drazner</surname>
                <given-names>MH</given-names>
              </name>
              <name>
                <surname>Fonarow</surname>
                <given-names>GC</given-names>
              </name>
              <name>
                <surname>Geraci</surname>
                <given-names>SA</given-names>
              </name>
              <name>
                <surname>Horwich</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Januzzi</surname>
                <given-names>JL</given-names>
              </name>
              <name>
                <surname>Johnson</surname>
                <given-names>MR</given-names>
              </name>
              <name>
                <surname>Kasper</surname>
                <given-names>EK</given-names>
              </name>
              <name>
                <surname>Levy</surname>
                <given-names>WC</given-names>
              </name>
              <name>
                <surname>Masoudi</surname>
                <given-names>FA</given-names>
              </name>
              <name>
                <surname>McBride</surname>
                <given-names>PE</given-names>
              </name>
              <name>
                <surname>McMurray</surname>
                <given-names>JJ</given-names>
              </name>
              <name>
                <surname>Mitchell</surname>
                <given-names>JE</given-names>
              </name>
              <name>
                <surname>Peterson</surname>
                <given-names>PN</given-names>
              </name>
              <name>
                <surname>Riegel</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Sam</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Stevenson</surname>
                <given-names>LW</given-names>
              </name>
              <name>
                <surname>Tang</surname>
                <given-names>WH</given-names>
              </name>
              <name>
                <surname>Tsai</surname>
                <given-names>EJ</given-names>
              </name>
              <name>
                <surname>Wilkoff</surname>
                <given-names>BL</given-names>
              </name>
            </person-group>
            <article-title>2013 ACCF/AHA guideline for the management of heart failure: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines.</article-title>
            <source>Circulation</source>
            <year>2013</year>
            <month>Oct</month>
            <day>15</day>
            <volume>128</volume>
            <issue>16</issue>
            <fpage>1810</fpage>
            <page-range>1810-52</page-range>
            <pub-id pub-id-type="pmid">23741057</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24161.r16">
          <label>16</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Yancy</surname>
                <given-names>CW</given-names>
              </name>
              <name>
                <surname>Jessup</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Bozkurt</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Butler</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Casey</surname>
                <given-names>DE</given-names>
              </name>
              <name>
                <surname>Drazner</surname>
                <given-names>MH</given-names>
              </name>
              <name>
                <surname>Fonarow</surname>
                <given-names>GC</given-names>
              </name>
              <name>
                <surname>Geraci</surname>
                <given-names>SA</given-names>
              </name>
              <name>
                <surname>Horwich</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Januzzi</surname>
                <given-names>JL</given-names>
              </name>
              <name>
                <surname>Johnson</surname>
                <given-names>MR</given-names>
              </name>
              <name>
                <surname>Kasper</surname>
                <given-names>EK</given-names>
              </name>
              <name>
                <surname>Levy</surname>
                <given-names>WC</given-names>
              </name>
              <name>
                <surname>Masoudi</surname>
                <given-names>FA</given-names>
              </name>
              <name>
                <surname>McBride</surname>
                <given-names>PE</given-names>
              </name>
              <name>
                <surname>McMurray</surname>
                <given-names>JJ</given-names>
              </name>
              <name>
                <surname>Mitchell</surname>
                <given-names>JE</given-names>
              </name>
              <name>
                <surname>Peterson</surname>
                <given-names>PN</given-names>
              </name>
              <name>
                <surname>Riegel</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Sam</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Stevenson</surname>
                <given-names>LW</given-names>
              </name>
              <name>
                <surname>Tang</surname>
                <given-names>WH</given-names>
              </name>
              <name>
                <surname>Tsai</surname>
                <given-names>EJ</given-names>
              </name>
              <name>
                <surname>Wilkoff</surname>
                <given-names>BL</given-names>
              </name>
              <collab>American College of Cardiology Foundation</collab>
              <collab>American Heart Association Task Force on Practice Guidelines</collab>
            </person-group>
            <article-title>2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines.</article-title>
            <source>J Am Coll Cardiol</source>
            <year>2013</year>
            <month>Oct</month>
            <day>15</day>
            <volume>62</volume>
            <issue>16</issue>
            <fpage>e147</fpage>
            <page-range>e147-239</page-range>
            <pub-id pub-id-type="pmid">23747642</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24161.r17">
          <label>17</label>
          <element-citation publication-type="journal">
            <person-group>
              <collab>WRITING COMMITTEE MEMBERS</collab>
              <name>
                <surname>Yancy</surname>
                <given-names>CW</given-names>
              </name>
              <name>
                <surname>Jessup</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Bozkurt</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Butler</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Casey</surname>
                <given-names>DE</given-names>
              </name>
              <name>
                <surname>Colvin</surname>
                <given-names>MM</given-names>
              </name>
              <name>
                <surname>Drazner</surname>
                <given-names>MH</given-names>
              </name>
              <name>
                <surname>Filippatos</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Fonarow</surname>
                <given-names>GC</given-names>
              </name>
              <name>
                <surname>Givertz</surname>
                <given-names>MM</given-names>
              </name>
              <name>
                <surname>Hollenberg</surname>
                <given-names>SM</given-names>
              </name>
              <name>
                <surname>Lindenfeld</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Masoudi</surname>
                <given-names>FA</given-names>
              </name>
              <name>
                <surname>McBride</surname>
                <given-names>PE</given-names>
              </name>
              <name>
                <surname>Peterson</surname>
                <given-names>PN</given-names>
              </name>
              <name>
                <surname>Stevenson</surname>
                <given-names>LW</given-names>
              </name>
              <name>
                <surname>Westlake</surname>
                <given-names>C</given-names>
              </name>
            </person-group>
            <article-title>2016 ACC/AHA/HFSA Focused Update on New Pharmacological Therapy for Heart Failure: An Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of America.</article-title>
            <source>Circulation</source>
            <year>2016</year>
            <month>Sep</month>
            <day>27</day>
            <volume>134</volume>
            <issue>13</issue>
            <fpage>e282</fpage>
            <page-range>e282-93</page-range>
            <pub-id pub-id-type="pmid">27208050</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24161.r18">
          <label>18</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Yancy</surname>
                <given-names>CW</given-names>
              </name>
              <name>
                <surname>Jessup</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Bozkurt</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Butler</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Casey</surname>
                <given-names>DE</given-names>
              </name>
              <name>
                <surname>Colvin</surname>
                <given-names>MM</given-names>
              </name>
              <name>
                <surname>Drazner</surname>
                <given-names>MH</given-names>
              </name>
              <name>
                <surname>Filippatos</surname>
                <given-names>GS</given-names>
              </name>
              <name>
                <surname>Fonarow</surname>
                <given-names>GC</given-names>
              </name>
              <name>
                <surname>Givertz</surname>
                <given-names>MM</given-names>
              </name>
              <name>
                <surname>Hollenberg</surname>
                <given-names>SM</given-names>
              </name>
              <name>
                <surname>Lindenfeld</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Masoudi</surname>
                <given-names>FA</given-names>
              </name>
              <name>
                <surname>McBride</surname>
                <given-names>PE</given-names>
              </name>
              <name>
                <surname>Peterson</surname>
                <given-names>PN</given-names>
              </name>
              <name>
                <surname>Stevenson</surname>
                <given-names>LW</given-names>
              </name>
              <name>
                <surname>Westlake</surname>
                <given-names>C</given-names>
              </name>
            </person-group>
            <article-title>2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of America.</article-title>
            <source>Circulation</source>
            <year>2017</year>
            <month>Aug</month>
            <day>08</day>
            <volume>136</volume>
            <issue>6</issue>
            <fpage>e137</fpage>
            <page-range>e137-e161</page-range>
            <pub-id pub-id-type="pmid">28455343</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24161.r19">
          <label>19</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hunt</surname>
                <given-names>SA</given-names>
              </name>
              <name>
                <surname>Abraham</surname>
                <given-names>WT</given-names>
              </name>
              <name>
                <surname>Chin</surname>
                <given-names>MH</given-names>
              </name>
              <name>
                <surname>Feldman</surname>
                <given-names>AM</given-names>
              </name>
              <name>
                <surname>Francis</surname>
                <given-names>GS</given-names>
              </name>
              <name>
                <surname>Ganiats</surname>
                <given-names>TG</given-names>
              </name>
              <name>
                <surname>Jessup</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Konstam</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>Mancini</surname>
                <given-names>DM</given-names>
              </name>
              <name>
                <surname>Michl</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Oates</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>Rahko</surname>
                <given-names>PS</given-names>
              </name>
              <name>
                <surname>Silver</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>Stevenson</surname>
                <given-names>LW</given-names>
              </name>
              <name>
                <surname>Yancy</surname>
                <given-names>CW</given-names>
              </name>
            </person-group>
            <article-title>2009 focused update incorporated into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines: developed in collaboration with the International Society for Heart and Lung Transplantation.</article-title>
            <source>Circulation</source>
            <year>2009</year>
            <month>Apr</month>
            <day>14</day>
            <volume>119</volume>
            <issue>14</issue>
            <fpage>e391</fpage>
            <page-range>e391-479</page-range>
            <pub-id pub-id-type="pmid">19324966</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24161.r20">
          <label>20</label>
          <element-citation publication-type="journal">
            <collab>Meta-analysis Global Group in Chronic Heart Failure (MAGGIC)</collab>
            <article-title>The survival of patients with heart failure with preserved or reduced left ventricular ejection fraction: an individual patient data meta-analysis.</article-title>
            <source>Eur Heart J</source>
            <year>2012</year>
            <month>Jul</month>
            <volume>33</volume>
            <issue>14</issue>
            <fpage>1750</fpage>
            <page-range>1750-7</page-range>
            <pub-id pub-id-type="pmid">21821849</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24161.r21">
          <label>21</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ho</surname>
                <given-names>KK</given-names>
              </name>
              <name>
                <surname>Anderson</surname>
                <given-names>KM</given-names>
              </name>
              <name>
                <surname>Kannel</surname>
                <given-names>WB</given-names>
              </name>
              <name>
                <surname>Grossman</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Levy</surname>
                <given-names>D</given-names>
              </name>
            </person-group>
            <article-title>Survival after the onset of congestive heart failure in Framingham Heart Study subjects.</article-title>
            <source>Circulation</source>
            <year>1993</year>
            <month>Jul</month>
            <volume>88</volume>
            <issue>1</issue>
            <fpage>107</fpage>
            <page-range>107-15</page-range>
            <pub-id pub-id-type="pmid">8319323</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24161.r22">
          <label>22</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Narang</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Cleland</surname>
                <given-names>JG</given-names>
              </name>
              <name>
                <surname>Erhardt</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Ball</surname>
                <given-names>SG</given-names>
              </name>
              <name>
                <surname>Coats</surname>
                <given-names>AJ</given-names>
              </name>
              <name>
                <surname>Cowley</surname>
                <given-names>AJ</given-names>
              </name>
              <name>
                <surname>Dargie</surname>
                <given-names>HJ</given-names>
              </name>
              <name>
                <surname>Hall</surname>
                <given-names>AS</given-names>
              </name>
              <name>
                <surname>Hampton</surname>
                <given-names>JR</given-names>
              </name>
              <name>
                <surname>Poole-Wilson</surname>
                <given-names>PA</given-names>
              </name>
            </person-group>
            <article-title>Mode of death in chronic heart failure. A request and proposition for more accurate classification.</article-title>
            <source>Eur Heart J</source>
            <year>1996</year>
            <month>Sep</month>
            <volume>17</volume>
            <issue>9</issue>
            <fpage>1390</fpage>
            <page-range>1390-403</page-range>
            <pub-id pub-id-type="pmid">8880025</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24161.r23">
          <label>23</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>McAlister</surname>
                <given-names>FA</given-names>
              </name>
              <name>
                <surname>Stewart</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Ferrua</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>McMurray</surname>
                <given-names>JJ</given-names>
              </name>
            </person-group>
            <article-title>Multidisciplinary strategies for the management of heart failure patients at high risk for admission: a systematic review of randomized trials.</article-title>
            <source>J Am Coll Cardiol</source>
            <year>2004</year>
            <month>Aug</month>
            <day>18</day>
            <volume>44</volume>
            <issue>4</issue>
            <fpage>810</fpage>
            <page-range>810-9</page-range>
            <pub-id pub-id-type="pmid">15312864</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
